期刊文献+

应用COX模型分析影响乳腺浸润性癌预后的生物学因素 被引量:3

An analysis of biological factors influencing prognosisof invasive breast cancer by COX model
下载PDF
导出
摘要 目的:探讨增殖细胞核抗原(PCNA)、原癌基因(CerbB2)、组织蛋白酶D(CathD)、转移抑制基因(nm23H1)、微血管数(MVC)、肥大细胞数(MC)、雌激素调节基因(PS2)、前列腺特异抗原(PSA)9个生物学因素与乳腺浸润性癌(invasivebreastcancer,IBC)预后的关系。方法:单因素分析:KaplanMeir生存曲线法。列联检验法。多因素分析:COX比例风险模型。结果:经COX模型MPLR方法检验显示出明显影响乳腺浸润性癌预后的4个因素,PS2、MVC、nm23H1、CerbB2.用比例风险模型计算出每个患者的预后指数PI(Prognosticindex),根据预后指数大小将86例乳腺癌术后患者分为2组,分别建立其术后生存率预测模型。结果提示PI值愈大,预后愈差,反之预后则好。结论:PS2、MVC、nm23H1、CerbB2是乳腺浸润性癌术后独立的预后指标。PI可能是临床评价病人预后、识别IBC术后复发的高危险性病人很有实用价值的指标。 Purpose:To detect the relationship between prognosis of invasive breast cancer(IBC)and nine biological factors:proliferating cell nuclear antigen(PCNA),C erbB 2,CathepsinD,nm23 H1,microvessel count(MVC),mast cell(MC),PS2 and prostate specific antigen(PSA).Methods:Univariate analysis:Kaplan Meier survival curve,crosstabs statistics,multaivariate analysis:COX proportional hazard modle.Results:MPLR test whowed the factors wiich influencing prognosisof invasive breast cancer included PS2,MVC,nm23 H1 and C erbB 2.Using proportional hazard model,the PI(Prognostic index)of each cases were calculated.according to their PI,86 cases of breast cancer accepted surgical treatment were divided into 2 groups and the predicting model of survival rates in each group were determined.Result the larger PI,the poorer the prognosis,the smaller PI,the better the prognosis.Conclusions:PS2,MVC,nm23 H1 and C erbB 2 coud be considered as the independent prognostic predictors in invasive breast cancer after resection.The PI may be a useful clinical tool for evaluating the prognosis of patients and identifying the population with“high risk”of recurrence and death in IBC.
出处 《癌症》 SCIE CAS CSCD 北大核心 1998年第5期341-342,345,共3页 Chinese Journal of Cancer
基金 广州市卫生局科研基金
关键词 COX模型 预后 乳腺癌 浸润性 生物学因素 Breast neoplasm COX model Prognosis
  • 相关文献

参考文献10

二级参考文献7

共引文献18

同被引文献28

  • 1高峰,王仁安,韩德宽,孙可淳.Cox模型在喉癌全切术患者预后分析中的应用[J].中华预防医学杂志,1995,29(6):367-367. 被引量:1
  • 2邵志敏 张杰 李方明 见:沈镇宙 邵志敏.乳腺癌的预后因素[A].见:沈镇宙,邵志敏.现代乳腺肿瘤学进展[C].上海:上海科学技术文献出版社,2002.4,79--]00.
  • 3邹丽琰 见:李佩文 邹丽琰 主编.乳腺癌的发生、发展及预后[A].见:李佩文,邹丽琰,主编.乳腺癌综合治疗学[C].北京:中国中医药出版社,1999.4,48.
  • 4Jukkola A,Bloigu R,Soini Y,et al.C—erb-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatmint in advanced disease.Eur J Cancer,2001;37:347~354.
  • 5Mao HS,Liu H,Fu XL,et al.Lose of nm23 expression predicts distal metastasis and poor survival for breast cancer.Int Joneol,2001;18(3):507-511.
  • 6Niskanen E, Blomqvist C, Franssila K, et al. Predictive value of c-er- B- 2. P53, cathepsln - D and histology of the primary tumor in metastasis breast cancer . Br J Cancer, 1997;76:917-922.
  • 7Taylor WF,Pearson GR.Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma[J]. Ann Otol Rhinol Laryngol,1985,94:530
  • 8Pugliano FA, Piccirillo JF,Zequeira MR,et al.Clinical-severity staging system for oropharyngeal cancer.Arch Otolaryngol Head Neck Surg,1997,123:1118
  • 9Clemens JD,Feinstein AR,Holabird N, et al.A new clinical-anatomic staging system for evaluating prognosis and treatment of prostate cancer[J]. J Chronic Dis,1986,39:913
  • 10Shiozaki H,Doki Y,Kauanishi K,et al.Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancer[J].Surgery,2000,127:552

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部